Source link : https://newshealth.biz/health-news/targeted-therapy-reverses-weight-gain-from-rare-cause-of-obesity/
In a randomized trial, the MC4R agonist setmelanotide reduced BMI and hunger in patients with acquired hypothalamic obesity. After 1 year, participants lost 36.4 lb with setmelanotide but gained 5.3 lb on placebo. The findings supported setmelanotide’s recent label expansion. Treatment with setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, led to significant reductions in body […]
The post Targeted Therapy Reverses Weight Gain From Rare Cause of Obesity first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-09 21:44:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8